From Scalable Solutions to Full-Stack AI Infrastructure, GIGABYTE to Present End-to-End AI Portfolio at COMPUTEX 2025
1.5.2025 03:00:00 CEST | Business Wire | Press Release
GIGABYTE Technology, a global leader in computing innovation, will return to COMPUTEX 2025 from May 20 to 23 under the theme "Omnipresence of Computing: AI Forward." Demonstrating how GIGABYTE’s complete spectrum of solutions spanning the AI lifecycle, from data center training to edge deployment and end-user applications reshapes the infrastructure to meet the next-gen AI demands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428101781/en/
From Scalable Solutions to Full-Stack AI Infrastructure, GIGABYTE to Present End-to-End AI Portfolio at COMPUTEX 2025
As generative AI continues to evolve, so do the demands for handling massive token volumes, real-time data streaming, and high-throughput compute environments. GIGABYTE’s end-to-end portfolio - ranging from rack-scale infrastructure to servers, cooling systems, embedded platforms, and personal computing—forms the foundation to accelerate AI breakthroughs across industries.
Scalable AI Infrastructure Starts Here: GIGAPOD with GPM Integration
At the heart of GIGABYTE exhibit is the enhanced GIGAPOD, a scalable GPU cluster designed for high-density data center and large AI model training. Designed for high-performance AI workloads, GIGAPOD supports the latest accelerating platforms including AMD Instinct™ MI325X and NVIDIA HGX™ H200. It is now integrated with GPM (GIGABYTE POD Manager), GIGABYTE’s proprietary infra and workflow management platform, which can enhance operational efficiency, streamline management, and optimize resource utilization across large-scale AI environments.
This year will also see the debut of the GIGAPOD Direct Liquid Cooling (DLC) variant, incorporating GIGABYTE’s G4L3 series servers and engineered for next-gen chips with TDPs exceeding 1,000W. The DLC solution is demonstrated in a 4+1 rack configuration in partnership with Kenmec, Vertiv, and nVent, featuring integrated cooling, power distribution, and network architecture. To help customers deploy faster and smarter, GIGABYTE offers end-to-end consulting services, including planning, deployment, and system validation, accelerating the path from concept to operation.
Built for Deployment: From Super Compute Module to Open Compute and Custom Workloads
As AI adoption shifts from training to deployment, GIGABYTE’s flexible system design and architecture ensure seamless transition and expansion. GIGABYTE presents the cutting-edge NVIDIA GB300 NVL72, a fully liquid-cooled, rack-scale design that unifies 72 NVIDIA Blackwell Ultra GPUs and 36 Arm®-based NVIDIA Grace™ CPUs in a single platform optimized for test-time scaling inference. Also shown at the booth are two OCP-compliant server racks: an 8OU AI system with NVIDIA HGX™ B200 integrated with Intel® Xeon® processors, and an ORV3 CPU-based storage rack with JBOD design to maximize density and throughput.
GIGABYTE also exhibits modular and diverse servers from high-performance GPU to storage-optimized to meet different AI workloads:
- Accelerated Compute: Air- and liquid-cooled servers for the latest AMD Instinct™MI325X, Intel® Gaudi® 3, and NVIDIA HGX™ B300 GPU platforms, optimized for GPU-to-GPU interconnects
- CXL Technology: CXL-enabled systems unlock shared memory pools across CPUs for real-time AI inference
- High-density Compute & Storage: Multi-node servers packed with high-core count CPUs and NVMe/E1.S storage, developed in collaboration with Solidigm, ADATA, Kioxia, and Seagate
- Cloud & Edge Platforms: Blade and node solutions optimized for power, thermal efficiency, and workload diversity—ideal for hyperscalers and managed service providers
Bringing AI to the Edge—and to Everyone
Extending AI to real-world applications, GIGABYTE introduces a new generation of embedded systems and mini PCs that bring compute closer to where data is generated.
Jetson-Powered Embedded Systems: Featuring NVIDIA® Jetson Orin™, these rugged platforms power real-time edge AI in industrial automation, robotics, and machine vision.
BRIX Mini PCs: Compact yet powerful, the latest BRIX systems include onboard NPUs and support Microsoft Copilot+ and Adobe AI tools, perfect for lightweight AI inference at the edge.
Expanding leadership from cloud to the edge, GIGABYTE delivers powerful on-premises AI acceleration with our advanced Z890/X870 motherboards and cutting-edge GeForce RTX 50 and Radeon RX 9000 Series graphics cards. The innovative AI TOP local AI computing solution simplifies complex AI workflows through memory offloading and multi-node clustering capabilities. This AI innovation extends throughout our consumer lineup - from Microsoft-certified Copilot+ AI PCs and gaming powerhouses to high-refresh OLED monitors. On laptops, the exclusive "Press and Speak" GIMATE AI agent enables intuitive hardware control, enhancing both productivity and everyday AI experiences.
GIGABYTE invites everyone to explore the AI Forward era, defined by scalable architecture, precision engineering, and a commitment to accelerating progress.
https://www.gigabyte.com/Events/Computex
View source version on businesswire.com: https://www.businesswire.com/news/home/20250428101781/en/
Contacts
Michael Pao brand@GIGABYTE.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom